Nifty
:
24971.90
Sensex
:
81896.79
-140.50 (-0.56%)
-511.38 (-0.62%)
Nifty
Sensex
:
:
24971.90
81896.79
-140.50 (-0.56%)
-511.38 (-0.62%)

Max Healthcare Institute Ltd.

Hospital & Healthcare Services

Rating :
62/99

BSE: 543220 | NSE: MAXHEALTH

NSE BSE
1190.20
23-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1202.1
  •  1208.9
  •  1185.5
  •  1213.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1344872
  •  1609532042.1
  •  1256.2
  •  836.6

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,15,909.07
  • 107.73
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,17,716.01
  • 0.13%
  • 12.36

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 23.74%
  • 0.13%
  • 3.31%
  • FII
  • DII
  • Others
  • 54.74%
  • 16.69%
  • 1.39%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.91
  • 38.55
  • 11.15

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.72
  • 73.73
  • 9.56

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 141.37
  • 20.46

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 73.75
  • 67.48

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 7.45
  • 8.73

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 44.65
  • 45.15

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
10.89
11.07
19
23.77
P/E Ratio
109.29
107.52
62.64
50.07
Revenue
5309
7028
10494
12633
EBITDA
1492
1849
2880
3540
Net Income
1058
1076
1805
2263
ROA
9.6
7.9
11.6
13.5
P/B Ratio
15.06
12.33
9.60
8.16
ROE
13.37
12.1
16.39
17.22
FCFF
317
493
328
1033
FCFF Yield
0.28
0.43
0.29
0.91
Net Debt
200
2328
1235
337
BVPS
79.03
96.5
124
145.92

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
1,909.74
1,422.90
34.21%
1,868.31
1,334.97
39.95%
1,707.46
1,363.16
25.26%
1,542.95
1,284.99
20.07%
Expenses
1,398.12
1,040.24
34.40%
1,369.18
949.11
44.26%
1,256.92
975.81
28.81%
1,155.54
947.61
21.94%
EBITDA
511.62
382.66
33.70%
499.13
385.86
29.36%
450.54
387.35
16.31%
387.41
337.38
14.83%
EBIDTM
26.79%
26.89%
26.72%
28.90%
26.39%
28.42%
25.11%
26.26%
Other Income
46.92
44.12
6.35%
33.30
46.02
-27.64%
40.84
45.48
-10.20%
34.68
41.32
-16.07%
Interest
55.21
20.73
166.33%
52.39
11.24
366.10%
33.54
8.53
293.20%
23.88
19.39
23.16%
Depreciation
100.83
70.32
43.39%
97.54
60.96
60.01%
84.15
57.88
45.39%
76.90
55.82
37.76%
PBT
402.50
335.73
19.89%
308.87
359.68
-14.13%
373.69
366.42
1.98%
321.31
303.49
5.87%
Tax
83.50
84.19
-0.82%
70.07
70.34
-0.38%
91.88
89.74
2.38%
85.04
63.41
34.11%
PAT
319.00
251.54
26.82%
238.80
289.34
-17.47%
281.81
276.68
1.85%
236.27
240.08
-1.59%
PATM
16.70%
17.68%
12.78%
21.67%
16.50%
20.30%
15.31%
18.68%
EPS
3.28
2.59
26.64%
2.46
2.98
-17.45%
2.90
2.85
1.75%
2.43
2.47
-1.62%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 16
Mar 15
Mar 14
Net Sales
7,028.46
5,406.02
4,562.60
3,936.55
2,507.97
1,059.03
1,691.02
1,445.40
1,133.61
944.46
Net Sales Growth
30.01%
18.49%
15.90%
56.96%
136.82%
-37.37%
16.99%
27.50%
20.03%
 
Cost Of Goods Sold
1,477.05
1,118.52
922.01
922.90
594.41
217.31
364.46
398.63
345.95
328.00
Gross Profit
5,551.41
4,287.50
3,640.59
3,013.65
1,913.56
841.72
1,326.56
1,046.77
787.66
616.46
GP Margin
78.98%
79.31%
79.79%
76.56%
76.30%
79.48%
78.45%
72.42%
69.48%
65.27%
Total Expenditure
5,179.76
3,924.88
3,335.14
2,998.14
2,124.34
965.45
1,545.51
1,329.79
1,058.39
914.52
Power & Fuel Cost
-
77.54
69.04
62.67
51.37
22.72
46.06
40.73
32.60
29.63
% Of Sales
-
1.43%
1.51%
1.59%
2.05%
2.15%
2.72%
2.82%
2.88%
3.14%
Employee Cost
-
934.40
809.35
759.92
588.78
230.13
440.55
297.48
232.09
188.81
% Of Sales
-
17.28%
17.74%
19.30%
23.48%
21.73%
26.05%
20.58%
20.47%
19.99%
Manufacturing Exp.
-
1,348.42
1,195.50
995.21
670.35
336.05
112.01
16.97
293.99
244.08
% Of Sales
-
24.94%
26.20%
25.28%
26.73%
31.73%
6.62%
1.17%
25.93%
25.84%
General & Admin Exp.
-
382.92
303.70
226.23
165.14
129.84
563.52
476.29
142.24
114.53
% Of Sales
-
7.08%
6.66%
5.75%
6.58%
12.26%
33.32%
32.95%
12.55%
12.13%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
28.30
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
1.96%
0%
0%
Miscellaneous Exp.
-
63.08
35.54
31.21
54.29
29.40
18.91
99.69
11.52
9.47
% Of Sales
-
1.17%
0.78%
0.79%
2.16%
2.78%
1.12%
6.90%
1.02%
1.00%
EBITDA
1,848.70
1,481.14
1,227.46
938.41
383.63
93.58
145.51
115.61
75.22
29.94
EBITDA Margin
26.30%
27.40%
26.90%
23.84%
15.30%
8.84%
8.60%
8.00%
6.64%
3.17%
Other Income
155.74
189.05
152.31
131.51
134.97
48.08
66.72
29.78
27.27
23.48
Interest
165.02
59.89
83.86
100.87
179.46
83.24
101.27
73.06
61.16
62.25
Depreciation
359.42
244.98
232.19
221.12
174.09
45.64
102.64
86.62
78.38
55.46
PBT
1,406.37
1,365.32
1,063.72
747.93
165.05
12.78
8.32
-14.29
-37.05
-64.29
Tax
330.49
307.68
-39.79
133.85
45.85
-0.13
8.51
-0.02
0.00
0.36
Tax Rate
23.50%
22.54%
-3.74%
18.11%
-66.79%
-1.02%
102.28%
0.14%
0.00%
-0.56%
PAT
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-3.01
-13.77
-37.05
-64.65
PAT before Minority Interest
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-0.19
-14.27
-37.05
-64.65
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-2.82
0.50
0.00
0.00
PAT Margin
15.31%
19.56%
24.19%
15.37%
-4.57%
1.22%
-0.18%
-0.95%
-3.27%
-6.85%
PAT Growth
1.72%
-4.16%
82.38%
-
-
-
-
-
-
 
EPS
11.07
10.88
11.35
6.22
-1.18
0.13
-0.03
-0.14
-0.38
-0.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Shareholder's Funds
8,408.14
7,409.59
6,282.47
5,638.68
2,553.15
963.19
Share Capital
971.91
970.92
969.61
965.95
537.24
537.24
Total Reserves
7,368.75
6,397.04
5,290.74
4,646.22
2,015.91
425.95
Non-Current Liabilities
2,343.09
1,646.69
2,149.39
2,127.85
410.56
1,251.32
Secured Loans
1,060.33
496.08
628.91
842.32
105.73
889.10
Unsecured Loans
0.50
0.50
0.50
0.50
0.50
0.96
Long Term Provisions
75.47
60.48
59.79
60.19
40.66
18.02
Current Liabilities
1,248.71
1,045.57
757.27
776.93
1,009.95
1,140.03
Trade Payables
677.47
543.46
444.11
435.69
179.63
291.59
Other Current Liabilities
448.80
408.16
196.95
237.52
95.26
752.87
Short Term Borrowings
61.29
45.58
74.53
54.25
727.37
77.61
Short Term Provisions
61.15
48.37
41.68
49.47
7.69
17.96
Total Liabilities
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54
Net Block
8,720.66
7,038.70
7,017.58
6,536.38
850.95
2,192.37
Gross Block
9,902.43
7,958.37
7,759.60
7,099.22
1,252.16
2,557.37
Accumulated Depreciation
1,181.77
919.67
742.02
562.84
401.21
365.00
Non Current Assets
10,293.76
8,158.78
8,188.84
7,418.99
1,058.27
2,907.24
Capital Work in Progress
553.04
252.43
151.12
26.93
27.55
87.02
Non Current Investment
2.12
0.51
0.51
0.51
0.00
0.51
Long Term Loans & Adv.
727.51
673.93
757.17
679.63
70.06
535.51
Other Non Current Assets
227.40
193.21
262.46
175.54
109.71
91.83
Current Assets
1,706.18
1,943.07
1,000.29
1,124.47
2,915.39
447.30
Current Investments
0.00
0.00
0.00
0.00
2,182.06
0.00
Inventories
79.84
76.23
61.36
53.80
26.80
26.01
Sundry Debtors
462.69
336.12
385.36
365.89
96.09
362.61
Cash & Bank
1,099.27
1,468.07
499.31
652.92
119.57
11.64
Other Current Assets
64.38
14.06
23.99
14.47
490.87
47.04
Short Term Loans & Adv.
40.79
48.59
30.27
37.39
478.76
36.06
Net Current Assets
457.47
897.50
243.02
347.54
1,905.44
-692.73
Total Assets
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
1,121.80
1,284.13
740.52
117.86
77.09
88.95
PBT
1,365.32
1,063.72
738.90
-68.65
12.78
8.32
Adjustment
184.85
225.84
241.22
504.74
109.44
156.89
Changes in Working Capital
-159.09
155.69
-130.54
-376.25
-38.84
-48.13
Cash after chg. in Working capital
1,391.08
1,445.25
849.58
59.84
83.38
117.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-269.28
-161.12
-109.06
58.02
-6.29
-28.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,285.45
-102.32
-763.80
-73.00
-2,640.70
-16.53
Net Fixed Assets
-450.48
-140.69
-1,687.37
-2,982.65
557.88
Net Investments
-440.62
-27.73
932.29
91.94
-1,701.27
Others
-394.35
66.10
-8.72
2,817.71
-1,497.31
Cash from Financing Activity
-263.74
-288.56
-294.17
191.33
2,353.12
-73.95
Net Cash Inflow / Outflow
-427.39
893.25
-317.45
236.19
-210.49
-1.53
Opening Cash & Equivalents
1,374.33
480.97
626.59
111.01
321.50
9.13
Closing Cash & Equivalent
979.84
1,374.33
309.14
626.59
111.01
7.60

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
85.82
75.89
64.57
58.10
47.52
17.93
ROA
9.57%
11.44%
6.82%
-1.83%
0.35%
-0.01%
ROE
13.47%
16.19%
10.19%
-2.80%
0.73%
-0.02%
ROCE
16.26%
15.32%
12.38%
2.22%
3.57%
5.32%
Fixed Asset Turnover
0.61
0.58
0.53
0.60
0.56
0.67
Receivable days
26.97
28.86
34.83
33.62
79.05
66.97
Inventory Days
5.27
5.50
5.34
5.87
9.10
5.86
Payable days
199.21
195.48
173.98
188.92
99.45
94.83
Cash Conversion Cycle
-166.97
-161.11
-133.81
-149.44
-11.30
-22.01
Total Debt/Equity
0.14
0.08
0.12
0.16
0.33
1.05
Interest Cover
23.80
13.68
8.33
0.62
1.15
1.08

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Max Healthcare Institute reports 27% jump in Q4 consolidated net profit
    21st May 2025, 15:12 PM

    The total consolidated income of the company increased by 33.38% at Rs 1,956.66 crore for Q4FY25

    Read More
  • Max Healthcare Institute’s arm executes sale deed for acquisition of land and building in UP
    17th May 2025, 11:12 AM

    This strategic acquisition paves the way for the addition of around 140 beds at MSSH, Vaishali over period of next 30 months

    Read More
  • Max Healthcare Institute planning to invest Rs 6,000 crore by 2028
    29th Apr 2025, 16:44 PM

    Max Healthcare, which operates 22 healthcare facilities with around 5,000 beds currently could have around 30 hospitals by 2028

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.